| 1. | At the molecular level amanitin toxins cause damage to cells of these organs.
|
| 2. | The oral of ?-amanitin is approximately 0.1 mg / kg.
|
| 3. | ?-Amanitin can also be used to determine which types of RNA polymerase are present.
|
| 4. | This is done by testing the sensitivity of the polymerase in the presence of ?-amanitin.
|
| 5. | ?-amanitin is able to travel through the bloodstream to reach the organs in the body.
|
| 6. | An example of a toxic peptide is alpha-amanitin, which is found in relatives of the death cap mushroom.
|
| 7. | Its principal toxic constituent, ?-amanitin, damages the liver and kidneys, often fatally, and has no known antidote.
|
| 8. | The genes encoding the proprotein for ?-amanitin belongs to the same family as those that encode for phallacidin ( a phallotoxin ).
|
| 9. | The tolerability and therapeutic window of amanitin-based ADCs has been determined in a variety of rodent and non-human primate models.
|
| 10. | In this case, the amanitin is diluted by " D4 " ( 1 : 10000 ) and 5-40 drops are given.
|